Interlaboratory-concordance of PD-L1 IHC for NSCLC

被引：0
|
作者：
Scheel, Andreas H.
Banfer, Gudrun
Baretton, Gustavo Bruno
Dietel, Manfred
Diezko, Rolf
Henkel, Thomas
Heukamp, Lukas C.
Jasani, Bharat
Johrens, Korinna
Kirchner, Thomas
Petersen, Iver
Reu, Simone
Schildhaus, Hans-Ulrich
Schirmacher, Peter
Tiemann, Markus
Warth, Arne
Weichert, Wilko
Wolf, Juergen
Ruschoff, Josef
Buettner, Reinhard
机构：
[1] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[2] Targos Mol Pathol GmbH, Kassel, Germany
[3] Univ Hosp Carl Gustav Carus, Dresden, Germany
[4] Charite, Inst Pathol, Berlin, Germany
[5] TARGOS Mol Pathol GmbH, Kassel, Germany
[6] Haematopathol Hamburg, Hamburg, Germany
[7] NEO New Oncol GmbH, Hamburg, Germany
[8] Charite, Inst Pathol, Campus Berlin Mitte, Berlin, Germany
[9] Univ Munich, Dept Pathol, Munich, Germany
[10] Univ Hosp Jena, Inst Pathol, Jena, Germany
[11] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany
[12] Univ Hosp Gottingen, Inst Pathol, Gottingen, Germany
[13] Heidelberg Univ, Patholog Inst, Heidelberg, Germany
[14] Universitatsklinikum Heidelberg, Dept Pathol, Translat Lung Res Ctr Heidelberg, Heidelberg, Germany
[15] Tech Univ Munich, Inst Pathol, Munich, Germany
[16] Univ Hosp Cologne, Lung Canc Grp Cologne, Ctr Integrated Oncol, Cologne, Germany
[17] Nordhessen & Targos Mol Pathol GmbH, Inst Pathol, Kassel, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20508
引用
收藏
页数：6
相关论文
共 50 条
  • [31] Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer
    Mitra, Shreya
    Prince, Emily A.
    Pratt, James
    Novotny, James, Jr.
    Chizhevsky, Vladislav
    Ragheb, Josette William
    Huron, David
    CANCER RESEARCH, 2021, 81 (04)
  • [32] Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx
    Skov, Birgit G.
    Skov, Torsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (07) : 453 - 459
  • [33] A Comparative Study of PD-L1 IHC 28-8 pharmDx and PD-L1 IHC 22C3 pharmDx on Malignancies from the Lung
    Skov, Birgit
    Skov, Torsten
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S815 - S816
  • [34] PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays
    Grabenstetter, Anne
    Jungbluth, Achim A.
    Frosina, Denise
    Hoda, Raza
    Dos Anjos, Carlos H.
    Patil, Sujata
    Sevilimedu, Varadan
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark E.
    Brogi, Edi
    Wen, Hannah Y.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (09) : 1274 - 1281
  • [35] Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
    Zhang, Jie
    Gao, Jing
    Li, Yanyan
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Han, Jindi
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Shen, Lin
    Fang, Jian
    THORACIC CANCER, 2015, 6 (04) : 534 - 538
  • [36] PD-L1 Overexpression in NSCLC Inversely Correlated with Survival of NSCLC Patients
    Zhong, Hua
    Zhou, Yan
    Han, Baohui
    Liu, Xianxun
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S669 - S669
  • [37] Comparison between four PD-L1 IHC assays and association with efficacy of Nivolumab in previously treated NSCLC patients regular
    Sato, Yuki
    Fujimoto, Daichi
    Uehara, Keiichiro
    Imaoka, Yuki
    Hayashi, Kentaro
    Ishida, Kaori
    Fukuoka, Junya
    Imai, Yukihiro
    Tomii, Keisuke
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Concordance of PD-L1 Expression Detection in Non-Small Cell Lung Cancer (NSCLC) Tissue Biopsy Specimens Between OncoTect iO Lung Assay and Immunohistochemistry (IHC)
    Young, Stephen
    Griego-Fullbright, Christen
    Wagner, Aaron
    Chargin, Amanda
    Patterson, Bruce K.
    Chabot-Richards, Devon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 (04) : 346 - 352
  • [39] Whole body PD-1 and PD-L1 PET in pts with NSCLC
    Niemeijer, A-L.
    Smit, E.
    Bahce, I.
    Hoekstra, O.
    Huisman, M.
    van Dongen, G. A.
    Windhorst, B.
    Hendrikse, N.
    Poot, A. J.
    Vugts, D.
    Leung, D. K.
    Hayes, W.
    Smith, R. A.
    Wilson, L. M.
    Thunnissen, E.
    de langen, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Mengke Niu
    Ming Yi
    Ning Li
    Suxia Luo
    Kongming Wu
    Experimental Hematology & Oncology, 10
12345